• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation.

作者信息

Schoots Ivo G, Padhani Anwar R

机构信息

Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, the Netherlands.

Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

出版信息

BJU Int. 2021 Feb;127(2):175-178. doi: 10.1111/bju.15277. Epub 2020 Nov 13.

DOI:10.1111/bju.15277
PMID:33089586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7894174/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05a3/7894174/ca86e5e5e70d/BJU-127-175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05a3/7894174/ca86e5e5e70d/BJU-127-175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05a3/7894174/ca86e5e5e70d/BJU-127-175-g001.jpg

相似文献

1
Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation.在首次前列腺癌诊断评估中，基于前列腺磁共振成像和前列腺特异性抗原密度进行风险适应性活检决策，以增强活检避免率。
BJU Int. 2021 Feb;127(2):175-178. doi: 10.1111/bju.15277. Epub 2020 Nov 13.
2
Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.对前列腺特异性抗原升高的初诊男性患者，磁共振成像引导下的孔内前列腺活检与系统经直肠超声引导下前列腺活检的前瞻性评估。
J Urol. 2014 Nov;192(5):1374-9. doi: 10.1016/j.juro.2014.05.090. Epub 2014 May 24.
3
High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility.短磁共振成像方案在前列腺癌初筛中的高诊断性能：磁共振成像可及性的下一步。
Eur Urol. 2019 Nov;76(5):574-581. doi: 10.1016/j.eururo.2019.05.029. Epub 2019 Jun 2.
4
Prebiopsy magnetic resonance studies for prostate cancer diagnosis.用于前列腺癌诊断的活检前磁共振研究。
Int J Urol. 2013 Feb;20(2):140-1. doi: 10.1111/j.1442-2042.2012.03201.x. Epub 2012 Oct 23.
5
The Diagnostic Performance of Multiparametric Magnetic Resonance Imaging to Detect Significant Prostate Cancer.多参数磁共振成像诊断效能检测显著前列腺癌。
J Urol. 2016 May;195(5):1428-1435. doi: 10.1016/j.juro.2015.10.140. Epub 2015 Oct 31.
6
Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy.经直肠 MRI 靶向前列腺穿刺活检对既往阴性前列腺穿刺活检后仍怀疑恶性且临床有意义前列腺癌的诊断准确性
Medicina (Kaunas). 2021 Jan 10;57(1):57. doi: 10.3390/medicina57010057.
7
A Single Center Evaluation of the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging against Transperineal Prostate Mapping Biopsy: An Analysis of Men with Benign Histology and Insignificant Cancer following Transrectal Ultrasound Biopsy.单中心评价多参数磁共振成像对经会阴前列腺图谱活检的诊断准确性：经直肠超声活检后良性组织学和无显著癌症的男性分析。
J Urol. 2018 Aug;200(2):302-308. doi: 10.1016/j.juro.2018.02.072. Epub 2018 Mar 1.
8
Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes.基于磁共振成像的前列腺特异抗原密度在预测经会阴扇形引导前列腺穿刺活检结果中的诊断价值。
Int Urol Nephrol. 2017 Aug;49(8):1335-1342. doi: 10.1007/s11255-017-1609-8. Epub 2017 May 5.
9
Diagnostic Performance of Multiparametric Magnetic Resonance Imaging and Fusion Targeted Biopsy to Detect Significant Prostate Cancer.多参数磁共振成像和融合靶向活检检测显著前列腺癌的诊断性能
Anticancer Res. 2017 Dec;37(12):6871-6877. doi: 10.21873/anticanres.12149.
10
Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value.前列腺癌主动监测中的系列磁共振成像：增量价值
J Urol. 2016 May;195(5):1421-1427. doi: 10.1016/j.juro.2015.11.055. Epub 2015 Dec 7.

引用本文的文献

1
AI-Assisted vs Unassisted Identification of Prostate Cancer in Magnetic Resonance Images.磁共振图像中人工智能辅助与非辅助前列腺癌识别
JAMA Netw Open. 2025 Jun 2;8(6):e2515672. doi: 10.1001/jamanetworkopen.2025.15672.
2
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series.根据多参数MRI指数病变位置定制使用前列腺特异性抗原密度：一项大型多机构系列研究的结果
Prostate Cancer Prostatic Dis. 2025 Jun 2. doi: 10.1038/s41391-025-00987-4.
3
Analysis of gray zone PSA and PSAD correlated with PIRADS v2.1 in the MRI-US fusion prostate biopsy era: a retrospective bi-centre study.

本文引用的文献

1
Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer.前列腺特异抗原密度（PSAD）联合前列腺影像报告和数据系统（PI-RADS）分类在检测临床显著性前列腺癌中的临床应用
Urol Oncol. 2020 Nov;38(11):846.e9-846.e16. doi: 10.1016/j.urolonc.2020.05.024. Epub 2020 Jun 21.
2
Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators.避免不必要的磁共振成像（MRI）和活检：基于前列腺特异性抗原密度、4Kscore 和风险计算器的 MRI 的阴性和阳性预测值。
Eur Urol Oncol. 2020 Oct;3(5):700-704. doi: 10.1016/j.euo.2019.08.015. Epub 2019 Sep 20.
3
MRI-US融合前列腺活检时代灰色地带前列腺特异性抗原（PSA）和前列腺特异性抗原密度（PSAD）与前列腺影像报告和数据系统（PIRADS）v2.1的相关性分析：一项回顾性双中心研究
Int Urol Nephrol. 2025 May 8. doi: 10.1007/s11255-025-04551-w.
4
ProstaPilot: A Comparative Study of Biparametric Magnetic Resonance Imaging Versus Prostate-specific Antigen as a Screening Test for Prostate Cancer.前列腺影像报告和数据系统（ProstaPilot）：双参数磁共振成像与前列腺特异性抗原作为前列腺癌筛查试验的比较研究
Eur Urol Open Sci. 2025 Apr 22;76:7-13. doi: 10.1016/j.euros.2025.03.016. eCollection 2025 Jun.
5
Personalised Prostate Cancer Diagnosis: Evaluating Biomarker-based Approaches to Reduce Unnecessary Magnetic Resonance Imaging and Biopsy Procedures.个性化前列腺癌诊断：评估基于生物标志物的方法以减少不必要的磁共振成像和活检程序。
Eur Urol Open Sci. 2025 Apr 15;75:106-119. doi: 10.1016/j.euros.2025.03.006. eCollection 2025 May.
6
The natural history of prostate cancer.前列腺癌的自然病史。
Can Urol Assoc J. 2025 Aug;19(8):275-281. doi: 10.5489/cuaj.9117.
7
Evaluating the performance of existing tools to predict clinically significant prostate cancer in men with indeterminate lesions on biparametric MRI and development of a novel multiplex model: a prospective cohort study.评估现有工具在预测双参数磁共振成像显示为不确定病变的男性中具有临床意义的前列腺癌的性能，并开发一种新型多重模型：一项前瞻性队列研究。
EClinicalMedicine. 2025 Apr 3;82:103191. doi: 10.1016/j.eclinm.2025.103191. eCollection 2025 Apr.
8
Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients with elevated PSA levels but negative MRI findings.前列腺特异抗原（PSA）水平升高但磁共振成像（MRI）结果为阴性的良性前列腺梗阻患者前列腺穿刺活检的最佳PSA密度阈值
BMC Urol. 2025 Mar 3;25(1):42. doi: 10.1186/s12894-025-01719-5.
9
The Diagnostic Value of Plasma Small Extracellular Vesicle-Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models.血浆小细胞外囊泡源性CAIX蛋白在前列腺癌及临床显著性前列腺癌中的诊断价值：预测模型研究
Prostate. 2025 Jun;85(8):723-741. doi: 10.1002/pros.24879. Epub 2025 Feb 27.
10
Patients with multiple mpMRI region of interests: should we omit targeted biopsies of secondary lesions?具有多个磁共振多参数成像（mpMRI）感兴趣区域的患者：我们是否应省略对继发性病变的靶向活检？
Abdom Radiol (NY). 2025 Feb 24. doi: 10.1007/s00261-025-04854-7.
Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study.
活检前 IMPROD 双参数磁共振成像联合前列腺特异性抗原密度在前列腺癌诊断中的应用：一项外部验证研究。
Eur Urol Oncol. 2020 Oct;3(5):648-656. doi: 10.1016/j.euo.2019.08.008. Epub 2019 Sep 6.
4
Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?利用多变量风险预测工具实现前列腺癌个体化诊断：应如何纳入前列腺 MRI？
World J Urol. 2020 Mar;38(3):531-545. doi: 10.1007/s00345-019-02899-0. Epub 2019 Aug 9.
5
Prebiopsy Biparametric Magnetic Resonance Imaging Combined with Prostate-specific Antigen Density in Detecting and Ruling out Gleason 7-10 Prostate Cancer in Biopsy-naïve Men.经活检初筛的男性中，使用双参数磁共振成像联合前列腺特异性抗原密度检测和排除 Gleason7-10 前列腺癌。
Eur Urol Oncol. 2019 May;2(3):311-319. doi: 10.1016/j.euo.2018.09.001. Epub 2018 Sep 27.
6
PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway.PI-RADS 指导委员会：PI-RADS 多参数 MRI 和 MRI 引导活检途径。
Radiology. 2019 Aug;292(2):464-474. doi: 10.1148/radiol.2019182946. Epub 2019 Jun 11.
7
Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer.用于检测前列腺癌的前列腺磁共振成像（MRI），无论是否进行MRI靶向活检及系统活检。
Cochrane Database Syst Rev. 2019 Apr 25;4(4):CD012663. doi: 10.1002/14651858.CD012663.pub2.
8
Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions.多变量风险预测工具，包括 MRI，用于前列腺癌诊断中的个体化活检决策：现状和未来方向。
World J Urol. 2020 Mar;38(3):517-529. doi: 10.1007/s00345-019-02707-9. Epub 2019 Mar 13.
9
Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.经直肠超声引导前列腺活检与多参数前列腺磁共振成像引导活检在前列腺特异性抗原升高的初次活检男性中的头对头比较：一项大型前瞻性多中心临床研究。
Eur Urol. 2019 Apr;75(4):570-578. doi: 10.1016/j.eururo.2018.11.023. Epub 2018 Nov 23.
10
Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naïve men with suspicion of prostate cancer.多中心评估磁共振成像引导经会阴前列腺穿刺活检在疑似前列腺癌的初次活检男性中的应用。
BJU Int. 2018 Jul;122(1):40-49. doi: 10.1111/bju.14049. Epub 2017 Nov 15.